{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:13:54Z","timestamp":1791753234626,"version":"4.3.4"},"reference-count":54,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The Haematological Malignancy Research Network (HMRN) was established in 2004 to provide robust generalizable data to inform clinical practice and research. It comprises an ongoing population\u2010based cohort of patients newly diagnosed by a single integrated haematopathology laboratory in two adjacent UK Cancer Networks (population 3\u00b76\u2003million). With an emphasis on primary\u2010source data, prognostic factors, sequential treatment\/response history, and socio\u2010demographic details are recorded to clinical trial standards. Data on 8131 patients diagnosed over the 4\u2003years 2004\u201308 are examined here using the latest World Health Organization classification. HMRN captures all diagnoses (adult and paediatric) and the diagnostic age ranged from 4\u2003weeks to 99\u2003years (median 70\u00b74\u2003years). In line with published estimates, first\u2010line clinical trial entry varied widely by disease subtype and age, falling from 59\u00b75% in those aged &lt;15\u2003years to 1\u00b79% in those aged over 75\u2003years \u2013 underscoring the need for contextual population\u2010based treatment and response data of the type collected by HMRN. The critical importance of incorporating molecular and prognostic markers into comparative survival analyses is illustrated with reference to diffuse\u2010large B\u2010cell lymphoma, acute myeloid leukaemia and myeloma. With respect to aetiology, several descriptive factors are highlighted and discussed, including the unexplained male predominance evident for most subtypes across all ages.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.08010.x","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T23:04:39Z","timestamp":1259708679000},"page":"739-753","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research"],"prefix":"10.1111","volume":"148","author":[{"given":"Alexandra","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Patmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Haematological Malignancy Research Network (members listed in )","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0902616"},{"key":"e_1_2_6_3_1","volume-title":"World Cancer Report 2008","author":"Boyle P.","year":"2008"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-013367"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1021"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.747"},{"key":"e_1_2_6_7_1","volume-title":"Cancer Reform Strategy","author":"Department of Health","year":"2007"},{"key":"e_1_2_6_8_1","volume-title":"Commissioning Assurance Handbook","author":"Department of Health","year":"2008"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.274"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011411"},{"key":"e_1_2_6_11_1","volume-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide","author":"Ferlay J.","year":"2004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1495"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109090"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392104"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"e_1_2_6_16_1","volume-title":"Cancer Registration: Principles and Methods, International Agency for Research on Cancer","author":"Jensen O.M.","year":"1991"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.334"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.342"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032520"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-136374"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0376-3"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.22.2720"},{"key":"e_1_2_6_24_1","volume-title":"Cancer Incidence and Mortality by Cancer Network, UK, 2005","author":"National Cancer Intelligence Network","year":"2009"},{"key":"e_1_2_6_25_1","volume-title":"One year Cancer Survival Trends, England 1985\u20132004","author":"National Cancer Intelligence Network","year":"2009"},{"key":"e_1_2_6_26_1","volume-title":"Cancer Incidence by Deprivation England, 1995\u20132004","author":"National Cancer Intelligence Network","year":"2009"},{"key":"e_1_2_6_27_1","volume-title":"Cancer Incidence and Survival by Major Ethnic Group, England, 2002\u20132006","author":"National Cancer Intelligence Network","year":"2009"},{"key":"e_1_2_6_28_1","volume-title":"NCRI Haematological Oncology Studies Group Annual Report 2008\/09","author":"National Cancer Research Network","year":"2009"},{"key":"e_1_2_6_29_1","volume-title":"NCRI Lymphoma Clinical Studies Group Annual Report 2008\u20139","author":"National Cancer Research Network","year":"2009"},{"key":"e_1_2_6_30_1","volume-title":"Improving Outcomes in Haematological Cancers: the Manual","author":"National Institute for Clinical Excellence","year":"2003"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-197368"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_2_6_33_1","volume-title":"Census: Standard Area Statistics (England and Wales, Scotland, Northern Ireland), 2001","author":"Office for National Statistics","year":"2001"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70028-2"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.904"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06863.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa075290"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031074"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.018"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1841"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.137"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl193"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0487"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.134"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70246-2"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-9-31"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070596"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403243"},{"key":"e_1_2_6_51_1","first-page":"91","article-title":"Cancer incidence and mortality in the United Kingdom and constituent countries, 2003\u201005","volume":"40","author":"Westlake S","year":"2008","journal-title":"Health Statistics Quarterly"},{"key":"e_1_2_6_52_1","volume-title":"International Classification of Disease for Oncology","author":"WHO","year":"2000"},{"key":"e_1_2_6_53_1","volume-title":"Tumours of Haematopoietic and Lymphoid Tissues","author":"WHO","year":"2001"},{"key":"e_1_2_6_54_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"WHO","year":"2008"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1732008100"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.08010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.08010.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:05:54Z","timestamp":1697439954000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.08010.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-2141.2009.08010.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.08010.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]},"assertion":[{"value":"2010-02-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}